Sort
46,585 grants matching “heart failure”
Project 3 (Mercola)
$513,960Mark Mercola · Stanford University · P01 · FY2022 · HL
Heart Failure Clinical Research Network - RCC
$513,959Christopher M O'Connor · Duke University · U01 · FY2007 · HL
HIV, Sleep, Nocturnal Non-dipping, and Cardiovascular Disease: a Tanzanian Cohort
$513,943Robert N Peck · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL
Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity
$513,934Steven William Hetts · University Of California, San Francisco · R01 · FY2017 · CA
Multi-level analysis of iron metabolism and treatment of chronic kidney disease
$513,916Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · DK
Prevention of anthracycline-induced cardiotoxicity by Nur77 activation
$513,844Jianxin Sun · Thomas Jefferson University · R01 · FY2024 · HL
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
$513,760Jason V Baker · Hennepin Healthcare Research Institute · R01 · FY2024 · HL
Calcium and Cardiac Regeneration after Myocardial Infarction
$513,758Steven R Houser · Temple Univ Of The Commonwealth · R01 · FY2016 · HL
Dynamic tissue-specific modulation of redox stress using chemogenetics
$513,644Thomas Michel · Brigham And Women'S Hospital · R33 · FY2021 · HL
T-box transcription factor Tbx2 in coronary vascular development and disease
$513,610Chenleng Cai · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · HL
Novel Strategy of PDE5-mTOR Inhibition in Attenuation of Cancer Drug Cardiotoxicity
$513,579Anindita Das · Virginia Commonwealth University · R01 · FY2024 · HL
Nonlinear Ultrasound: an Imaging Biomarker of Intestinal Fibrosis in Crohn's Disease
$513,527Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2016 · DK
Systems Biology of Hypertrophic Heart Disease from Molecular Pathways to Organ System
$513,518Andrew D. McCulloch · University Of California, San Diego · R01 · FY2017 · HL
Dynamic tissue-specific modulation of redox stress using chemogenetics
$513,456Thomas Michel · Brigham And Women'S Hospital · R33 · FY2022 · HL
Mechanisms of cKit+ Cardiac Stem Cell-Mediated Repair in Ischemic Cardiomyopathy
$513,414John M Canty · State University Of New York At Buffalo · R01 · FY2015 · HL
Colony stimulating factor-1 in graft vascular disease
$513,386Nicholas E Sibinga · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · HL
The Wnt7a/ROR2 axis in the pathogenesis of pulmonary arterial hypertension
$513,370Vinicio A De Jesus Perez · Stanford University · R01 · FY2017 · HL
BNP not just a biomarker of cardiovascular disease
$513,324Zhenyu Li · Texas A&M University Health Science Ctr · R01 · FY2024 · HL
Improving medication adherence using family-focused and literacy-sensitive strategies in patients with heart failure
$513,321Jia-Rong Wu · University Of Kentucky · R01 · FY2023 · NR
Structure and Function of the Cardiac Na+-Ca2+ Exchanger
$513,240Kenneth Philipson · University Of California Los Angeles · R01 · FY2008 · HL
Tracking Stem Cells: Viability and Function in the Heart
$513,201Brigham And Women'S Hospital · R01 · FY2005 · HL
Presentation of Alloantigen by Human Vascular Cells
$513,144Jordan S Pober · Yale University · R01 · FY2012 · HL
Renal ion channels in the control of blood pressure
$513,138Alexander Staruschenko · University Of South Florida · R35 · FY2022 · HL
A nanoparticle-based vaccine targeting PCSK9
$513,123Bryce C Chackerian · University Of New Mexico Health Scis Ctr · R01 · FY2020 · HL
Controlling bactermic pneumococcal pneumonia with synthetic dominant-negative competence peptides
$513,105Gee W Lau · University Of Illinois At Urbana-Champaign · R01 · FY2021 · HL